Nano-bubbles in Covid patients’ blood could block infection from variants
Live MintScientists in the US have identified tiny natural bubbles containing the ACE2 protein in the blood of COVID-19 patients that can block infection from broad strains of the SARS-CoV-2 virus. "Whenever a new mutant strain of SARS-CoV-2 surges, the original vaccine and therapeutic antibodies may lose power against Alpha, Beta, Delta and the most recent, Omicron," said study co-senior author Huiping Liu, an associate professor at Northwestern University. "However, the beauty of evACE2 is its superpower in blocking broad strains of coronaviruses, including current SARS-CoV-2 and even future SARS coronaviruses from infecting humans," Liu said. The study in mice demonstrates the therapeutic potential of evACE2 in preventing or blocking SARS-CoV-2 infection when it is delivered to the airway via droplets, the researchers said.